3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
6
Neoplasms
4
Colonic Neoplasms
3
Prostatic Neoplasms
2
Patient Satisfaction
2
Ovarian Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Tuberculosis, Pulmonary
1
Thoracic Diseases
1
Supratentorial Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polyps
1
Pituitary Neoplasms
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Interventions
Pemetrexed
10
Cisplatin
9
Erlotinib Hydrochloride
8
Carboplatin
7
icotinib
5
Gefitinib
5
Docetaxel
5
endostar protein
3
Zoledronic Acid
3
Radiotherapy
3
Paclitaxel
3
Gemcitabine
3
Endostatins
3
Afatinib
3
tislelizumab
2
pembrolizumab
2
osimertinib
2
lorlatinib
2
flurbiprofen axetil
2
dexamethasone 21-phosphate
2
atezolizumab
2
Vinorelbine
2
Surgical Procedures, Operative
2
Saline Solution
2
Nivolumab
2
Drug Therapy
2
Dexamethasone
2
Chemoradiotherapy
2
trametinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Non-Small-Cell Lung
×
Propofol
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled